BIOMAT Database Logo BIOMAT Database Logo

Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein. 1983

J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard

A prospective study of 1,040 women who underwent delivery during 1977 at St. Bartholomew's Hospital was undertaken to evaluate the role of measurement of maternal circulating pregnancy-specific beta 1-glycoprotein (SP1) in the detection of high-risk pregnancy. A comparison of the predictive value of this test was also made with a variety of clinical, ultrasonic, and biochemical variables in the detection of high-risk pregnancies. The best antenatal predictors of fetal risk were severe preeclampsia and depressed maternal serum levels of human placental lactogen and SP1. It is suggested that measurement of SP1 may provide valuable information on fetal compromise in late pregnancy.

UI MeSH Term Description Entries
D010928 Placental Lactogen A polypeptide hormone of approximately 25 kDa that is produced by the SYNCYTIOTROPHOBLASTS of the PLACENTA, also known as chorionic somatomammotropin. It has both GROWTH HORMONE and PROLACTIN activities on growth, lactation, and luteal steroid production. In women, placental lactogen secretion begins soon after implantation and increases to 1 g or more a day in late pregnancy. Placental lactogen is also an insulin antagonist. Choriomammotropin,Chorionic Somatomammotropin, Human,Human Placental Lactogen,Lactogen Hormone, Placental,Mammotropic Hormone, Placental,Somatomammotropin, Chorionic,Choriomammotrophin,HCS (Human Chorionic Somatomammotropin),HPL (Human Placental Lactogen),PAPP-D,Placental Luteotropin,Pregnancy-Associated Plasma Protein D,Chorionic Somatomammotropin,Human Chorionic Somatomammotropin,Lactogen, Placental,Luteotropin, Placental,Placental Lactogen, Human,Placental Mammotropic Hormone,Pregnancy Associated Plasma Protein D
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D011268 Pregnancy-Specific beta 1-Glycoproteins Glycoproteins with the electrophoretic mobility of BETA-GLOBULINS, secreted by the placental TROPHOBLASTS into the maternal bloodstream during PREGNANCY. They can be detected 18 days after OVULATION and reach 200 mg/ml at the end of pregnancy. They are associated with fetal well-being. Pregnancy-Specific beta 1-Glycoprotein,SP1 Pregnancy Protein,Trophoblast-Specific beta 1-Glycoprotein,beta 1-Glycoprotein, Pregnancy-Specific,beta-1 Glycoprotein, Trophoblast-Specific,PAPP-B,PAPP-C,PSBG-1,Pregnancy Specific beta 1 Glycoprotein,Pregnancy Specific beta-1 Glycoprotein,Pregnancy Specific beta1-Glycoprotein.,Pregnancy-Associated Plasma Protein B,Pregnancy-Associated Plasma Protein C,Pregnancy-Associated beta-Plasma Protein,Pregnancy-Specific beta-1 Globulin,Schwangerschaftsprotein 1,Trophoblastic beta 1-Glycoprotein,Trophoblastic beta(1)-Globulin,Trophoblastic beta-Globulin,beta 1-Globulin, Trophoblast-Specific,1-Glycoproteins, Pregnancy-Specific beta,PAPP B,PSBG 1,Pregnancy Associated Plasma Protein B,Pregnancy Associated Plasma Protein C,Pregnancy Protein, SP1,Pregnancy Specific beta 1 Globulin,Pregnancy Specific beta 1 Glycoproteins,Protein, SP1 Pregnancy,Trophoblast Specific beta 1 Glycoprotein,Trophoblast-Specific beta 1-Globulin,Trophoblast-Specific beta-1 Glycoprotein,Trophoblastic beta Globulin,beta 1 Globulin, Trophoblast Specific,beta 1-Glycoproteins, Pregnancy-Specific,beta-1 Globulin, Pregnancy-Specific,beta-Globulin, Trophoblastic
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females

Related Publications

J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
[Pregnancy-specific beta 1-glycoprotein in high risk pregnancies].
January 1980, Archivio di ostetricia e ginecologia,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
Kinetic immunoturbidimetry: the measurement of pregnancy specific beta 1 glycoprotein.
December 1979, Clinica chimica acta; international journal of clinical chemistry,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy.
January 1980, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
Identification of pregnancy from bloodstains by radioimmunoassay for pregnancy specific beta 1-glycoprotein (SP1).
August 1987, Nihon hoigaku zasshi = The Japanese journal of legal medicine,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
[Pregnancy specific beta-1-glycoprotein].
January 1979, Duodecim; laaketieteellinen aikakauskirja,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
[Pregnancy specific beta 1 glycoprotein (SP-1)].
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
Pregnancy-specific beta-1 glycoprotein in ectopic pregnancy.
January 1980, American journal of obstetrics and gynecology,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
Molecular heterogeneity of pregnancy specific beta 1 glycoprotein: the effect on measurement by radioimmunoassay and electroimmunoassay.
January 1979, Journal of immunological methods,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
[SP-1: parameter for the high risk pregnancy. The pregnancy specific beta 1-glycoprotein in the serum of pregnant women with toxemia].
February 1981, Fortschritte der Medizin,
J G Grudzinskas, and Y B Gordon, and M Menabawey, and J N Lee, and J Wadsworth, and T Chard
Identification of pregnancy-specific beta 1-glycoprotein in the plasma of man with choriocarcinoma.
January 1979, Cellular and molecular biology, including cyto-enzymology,
Copied contents to your clipboard!